About Johnson & Johnson 
Johnson & Johnson
Pharmaceuticals & Biotechnology
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.
Company Coordinates 
Company Details
1 Johnson And Johnson Plz , NEW BRUNSWICK NJ : 08933-0001
Registrar Details
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 304 Schemes (25.69%)
Foreign Institutions
Held by 709 Foreign Institutions (16.9%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
Mr. Alex Gorsky
Chairman of the Board, Chief Executive Officer
Ms. Anne Mulcahy
Lead Independent Director
Dr. Mary Beckerle
Independent Director
Mr. D. Scott Davis
Independent Director
Mr. Ian Davis
Independent Director
Dr. Jennifer Doudna
Independent Director
Revenue and Profits:
Net Sales:
23,741 Million
(Quarterly Results - Jun 2025)
Net Profit:
5,537 Million
Pharmaceuticals & Biotechnology
USD 515,810 Million (Large Cap)
23.00
NA
2.56%
0.41
25.10%
6.57






